Clinical trial Recruiting at 2 sites Interventional Ages 18 to 65

Investigating how different types of wheat affect non-celiac wheat sensitivity

Official title: Clinical Response and Cytokines Production After Challenge With Different Wheat Genotypes in Patients With Not-celiac Wheat Sensitivity.

Run by University of Palermo · NCT03024775 · Data updated 2026-11-12

This study is testing whether people with non-celiac wheat sensitivity feel better when eating ancient types of wheat compared to modern varieties.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorUniversity of Palermo
Academic / other
Locations2 sites (Sciacca, Agrigento and 1 other locations)
StatusRecruiting
StartedJanuary 1, 2017
Main results expectedJune 1, 2024
Study endsDecember 1, 2026
Registry record updatedJune 22, 2025
Trial IDNCT03024775 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults diagnosed with non-celiac wheat sensitivity who have negative tests for celiac disease and wheat allergy.

Probably not a fit

Patients under 18 years old or those with positive tests for celiac disease or wheat allergy will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the effects of ancient versus modern wheat genotypes on patients with non-celiac wheat sensitivity (NCWS). It will assess whether ancient wheats are better tolerated than modern varieties by analyzing the symptoms triggered by different wheat components, including amylase/trypsin inhibitors (ATIs). Participants will undergo a double-blind, placebo-controlled challenge to evaluate their reactions to various wheat types. The study seeks to provide scientific data to support or refute common beliefs about wheat tolerance in NCWS patients.

Why it matters

Potential benefit: If successful, this study could lead to better dietary recommendations for individuals suffering from non-celiac wheat sensitivity.

How similar studies have gone: While there is ongoing interest in the effects of different wheat types on sensitivity, this specific approach is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

All the patients will meet the recently proposed criteria:

* negative serum anti-tissue transglutaminase and antiendomysium (EmA) immunoglobulin (Ig)A and IgG antibodies
* absence of intestinal villous atrophy
* IgE-mediated immunoallergic tests negative to wheat (skin prick tests and/or serum specific IgE detection)
* follow-up duration \>12 months after the initial diagnosis
* at least two outpatient visits during the follow-up period.

Adjunctive criteria adopted in our patients will be:

* resolution of the gastrointestinal symptoms on a standard elimination diet, without wheat, cow's milk, egg, tomato, chocolate, or other food(s) causing self-reported symptoms
* symptom reappearance on DBPC wheat challenge, performed as described previously. As in previous studies, DBPC cow's milk protein challenge and other "open" food challenges will be also performed.

Exclusion Criteria:

Exclusion criteria will be:

* age \<18 years
* positive EmA in the culture medium of the duodenal biopsies, even if the villi to crypts ratio in the duodenal mucosa was normal
* self-exclusion of wheat from the diet and refusal to reintroduce it before entering the study
* other organic gastrointestinal diseases (i.e. careful exclusion of Crohn's disease)
* concomitant treatment with steroids and/or antihistamines.

Where it's running

  • Department of Internal Medicine, Giovanni Paolo II Hospital of Sciacca
    Sciacca, Agrigento, Italy
    Recruiting
  • Department of Internal Medicine, University Hospital of Palermo
    Palermo, Palermo, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.